메뉴 건너뛰기




Volumn 152, Issue 5, 2013, Pages 1065-1076

Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma

(31)  Snuderl, Matija a,b,k   Batista, Ana a,b   Kirkpatrick, Nathaniel D a,b   De Almodovar, Carmen Ruiz c,d   Riedemann, Lars a,b   Walsh, Elisa C a,b   Anolik, Rachel a,b   Huang, Yuhui a,b   Martin, John D a,b   Kamoun, Walid a,b   Knevels, Ellen c,d   Schmidt, Thomas c,d   Farrar, Christian T a,b   Vakoc, Benjamin J a,b,e   Mohan, Nishant a,b,e   Chung, Euiheon a,b   Roberge, Sylvie a,b   Peterson, Teresa a,b   Bais, Carlos f   Zhelyazkova, Boryana H a   more..


Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPAMINE; NEUROPILIN 1; PLACENTAL GROWTH FACTOR; SONIC HEDGEHOG PROTEIN; VASCULOTROPIN RECEPTOR 1;

EID: 84874760414     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.01.036     Document Type: Article
Times cited : (206)

References (47)
  • 3
    • 79956328903 scopus 로고    scopus 로고
    • Molecular mechanisms and clinical applications of angiogenesis
    • Carmeliet, P., and Jain, R.K. (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307.
    • (2011) Nature , vol.473 , pp. 298-307
    • Carmeliet, P.1    Jain, R.K.2
  • 4
    • 19244379078 scopus 로고    scopus 로고
    • Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
    • Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575-583.
    • (2001) Nat. Med. , vol.7 , pp. 575-583
    • Carmeliet, P.1    Moons, L.2    Luttun, A.3    Vincenti, V.4    Compernolle, V.5    De Mol, M.6    Wu, Y.7    Bono, F.8    Devy, L.9    Beck, H.10
  • 5
    • 26644471951 scopus 로고    scopus 로고
    • Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
    • Casanovas, O., Hicklin, D.J., Bergers, G., and Hanahan, D. (2005). Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8, 299-309.
    • (2005) Cancer Cell , vol.8 , pp. 299-309
    • Casanovas, O.1    Hicklin, D.J.2    Bergers, G.3    Hanahan, D.4
  • 7
    • 70349280375 scopus 로고    scopus 로고
    • VEGFR1- activity-independent metastasis formation
    • Dawson, M.R., Duda, D.G., Fukumura, D., and Jain, R.K. (2009). VEGFR1- activity-independent metastasis formation. Nature 461, E4.
    • (2009) Nature , vol.461
    • Dawson, M.R.1    Duda, D.G.2    Fukumura, D.3    Jain, R.K.4
  • 10
    • 56749174211 scopus 로고    scopus 로고
    • FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy?
    • Fischer, C., Mazzone, M., Jonckx, B., and Carmeliet, P. (2008). FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat. Rev. Cancer 8, 942-956.
    • (2008) Nat. Rev. Cancer , vol.8 , pp. 942-956
    • Fischer, C.1    Mazzone, M.2    Jonckx, B.3    Carmeliet, P.4
  • 14
    • 77950279550 scopus 로고    scopus 로고
    • Tumor microvasculature and microenvironment: Novel insights through intravital imaging in pre-clinical models
    • Fukumura, D., Duda, D.G., Munn, L.L., and Jain, R.K. (2010). Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation 17, 206-225.
    • (2010) Microcirculation , vol.17 , pp. 206-225
    • Fukumura, D.1    Duda, D.G.2    Munn, L.L.3    Jain, R.K.4
  • 15
    • 79960096827 scopus 로고    scopus 로고
    • Normalization of the vasculature for treatment of cancer and other diseases
    • Goel, S., Duda, D.G., Xu, L., Munn, L.L., Boucher, Y., Fukumura, D., and Jain, R.K. (2011). Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 91, 1071-1121.
    • (2011) Physiol. Rev. , vol.91 , pp. 1071-1121
    • Goel, S.1    Duda, D.G.2    Xu, L.3    Munn, L.L.4    Boucher, Y.5    Fukumura, D.6    Jain, R.K.7
  • 16
    • 0030657417 scopus 로고    scopus 로고
    • Second cancers after medulloblastoma: Population-based results from the United States and Sweden
    • Goldstein, A.M., Yuen, J., and Tucker, M.A. (1997). Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control 8, 865-871.
    • (1997) Cancer Causes Control , vol.8 , pp. 865-871
    • Goldstein, A.M.1    Yuen, J.2    Tucker, M.A.3
  • 17
    • 0021952476 scopus 로고
    • Neuronal regulation of astroglial morphology and proliferation in vitro
    • Hatten, M.E. (1985). Neuronal regulation of astroglial morphology and proliferation in vitro. J. Cell Biol. 100, 384-396.
    • (1985) J. Cell Biol. , vol.100 , pp. 384-396
    • Hatten, M.E.1
  • 19
    • 0032482978 scopus 로고    scopus 로고
    • Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
    • Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., and Shibuya, M. (1998). Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95, 9349-9354.
    • (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 9349-9354
    • Hiratsuka, S.1    Minowa, O.2    Kuno, J.3    Noda, T.4    Shibuya, M.5
  • 20
    • 35548934659 scopus 로고    scopus 로고
    • AlphaPlGF: A new kid on the antiangiogenesis block
    • Jain, R.K., and Xu, L. (2007). alphaPlGF: a new kid on the antiangiogenesis block. Cell 131, 443-445.
    • (2007) Cell , vol.131 , pp. 443-445
    • Jain, R.K.1    Xu, L.2
  • 21
    • 84856819648 scopus 로고    scopus 로고
    • A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours
    • Lassen, U., Nielsen, D.L., Srensen, M., Winstedt, L., Niskanen, T., Stenberg, Y., Pakola, S., Stassen, J.M., and Glazer, S. (2012). A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours. Br. J. Cancer 106, 678-684.
    • (2012) Br. J. Cancer , vol.106 , pp. 678-684
    • Lassen, U.1    Nielsen, D.L.2    Srensen, M.3    Winstedt, L.4    Niskanen, T.5    Stenberg, Y.6    Pakola, S.7    Stassen, J.M.8    Glazer, S.9
  • 23
    • 80053041612 scopus 로고    scopus 로고
    • Monoclonal antibody TB- 403: A first-in-human, Phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects
    • Martinsson-Niskanen, T., Riisbro, R., Larsson, L., Winstedt, L., Stenberg, Y., Pakola, S., Stassen, J.M., and Glazer, S. (2011). Monoclonal antibody TB- 403: a first-in-human, Phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects. Clin. Ther. 33, 1142-1149.
    • (2011) Clin. Ther. , vol.33 , pp. 1142-1149
    • Martinsson-Niskanen, T.1    Riisbro, R.2    Larsson, L.3    Winstedt, L.4    Stenberg, Y.5    Pakola, S.6    Stassen, J.M.7    Glazer, S.8
  • 24
    • 79960935826 scopus 로고    scopus 로고
    • Hedgehog fights back: Mechanisms of acquired resistance against Smoothened antagonists
    • Metcalfe, C., and de Sauvage, F.J. (2011). Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists. Cancer Res. 71, 5057-5061.
    • (2011) Cancer Res. , vol.71 , pp. 5057-5061
    • Metcalfe, C.1    De Sauvage, F.J.2
  • 25
    • 84861307333 scopus 로고    scopus 로고
    • Inhibition of placenta growth factor with TB-403: A novel antiangiogenic cancer therapy
    • Nielsen, D.L., and Sengelv, L. (2012). Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy. Expert Opin. Biol. Ther. 12, 795-804.
    • (2012) Expert Opin. Biol. Ther. , vol.12 , pp. 795-804
    • Nielsen, D.L.1    Sengelv, L.2
  • 29
    • 78651461701 scopus 로고    scopus 로고
    • HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF
    • Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M.L., Segura, I., Li, X., Knevels, E., et al. (2011). HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 19, 31-44.
    • (2011) Cancer Cell , vol.19 , pp. 31-44
    • Rolny, C.1    Mazzone, M.2    Tugues, S.3    Laoui, D.4    Johansson, I.5    Coulon, C.6    Squadrito, M.L.7    Segura, I.8    Li, X.9    Knevels, E.10
  • 31
    • 34249065621 scopus 로고    scopus 로고
    • Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: Results of patients treated in the prospective multicenter trial HIT91
    • Rutkowski, S., von Bueren, A., von Hoff, K., Hartmann, W., Shalaby, T., Deinlein, F., Warmuth-Metz, M., Soerensen, N., Emser, A., Bode, U., et al. (2007). Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT91. Clin. Cancer Res. 13, 2651-2657.
    • (2007) Clin. Cancer Res. , vol.13 , pp. 2651-2657
    • Rutkowski, S.1    Von Bueren, A.2    Von Hoff, K.3    Hartmann, W.4    Shalaby, T.5    Deinlein, F.6    Warmuth-Metz, M.7    Soerensen, N.8    Emser, A.9    Bode, U.10
  • 35
    • 79956217891 scopus 로고    scopus 로고
    • A first-in-human phase i study to evaluate the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously every three weeks in patients with advanced solid tumors
    • Weekes, C.D., Hegde, P., Xin, Y., Yu, R., Xiang, H., Beeram, M., Gore, L., Brachmann, R.K., and Patnaik, A. (2010). A first-in-human phase I study to evaluate the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously every three weeks in patients with advanced solid tumors. J. Clin. Oncol. 28, 3014.
    • (2010) J. Clin. Oncol. , vol.28 , pp. 3014
    • Weekes, C.D.1    Hegde, P.2    Xin, Y.3    Yu, R.4    Xiang, H.5    Beeram, M.6    Gore, L.7    Brachmann, R.K.8    Patnaik, A.9
  • 36
    • 77949719411 scopus 로고    scopus 로고
    • Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts
    • Walter, K., Omura, N., Hong, S.M., Griffith, M., Vincent, A., Borges, M., and Goggins, M. (2010). Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts. Clin. Cancer Res. 16, 1781-1789.
    • (2010) Clin. Cancer Res. , vol.16 , pp. 1781-1789
    • Walter, K.1    Omura, N.2    Hong, S.M.3    Griffith, M.4    Vincent, A.5    Borges, M.6    Goggins, M.7
  • 37
    • 34548703367 scopus 로고    scopus 로고
    • Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma
    • Xu, L., and Jain, R.K. (2007). Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma. Mol. Cancer Res. 5, 873-880.
    • (2007) Mol. Cancer Res. , vol.5 , pp. 873-880
    • Xu, L.1    Jain, R.K.2
  • 38
    • 33646227427 scopus 로고    scopus 로고
    • Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models
    • Xu, L., Cochran, D.M., Tong, R.T., Winkler, F., Kashiwagi, S., Jain, R.K., and Fukumura, D. (2006). Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models. Cancer Res. 66, 3971-3977.
    • (2006) Cancer Res. , vol.66 , pp. 3971-3977
    • Xu, L.1    Cochran, D.M.2    Tong, R.T.3    Winkler, F.4    Kashiwagi, S.5    Jain, R.K.6    Fukumura, D.7
  • 39
  • 42
    • 77954062987 scopus 로고    scopus 로고
    • Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases
    • Chung, E., Yamashita, H., Au, P., Tannous, B.A., Fukumura, D., and Jain, R.K. (2009). Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. PLoS ONE 4, e8316.
    • (2009) PLoS ONE , vol.4
    • Chung, E.1    Yamashita, H.2    Au, P.3    Tannous, B.A.4    Fukumura, D.5    Jain, R.K.6
  • 43
    • 0346250110 scopus 로고    scopus 로고
    • Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis
    • Jenkins, D.E., Oei, Y., Hornig, Y.S., Yu, S.F., Dusich, J., Purchio, T., and Contag, P.R. (2003). Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin. Exp. Metastasis 20, 733-744.
    • (2003) Clin. Exp. Metastasis , vol.20 , pp. 733-744
    • Jenkins, D.E.1    Oei, Y.2    Hornig, Y.S.3    Yu, S.F.4    Dusich, J.5    Purchio, T.6    Contag, P.R.7
  • 44
    • 66349121063 scopus 로고    scopus 로고
    • Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice
    • Kamoun, W.S., Ley, C.D., Farrar, C.T., Duyverman, A.M., Lahdenranta, J., Lacorre, D.A., Batchelor, T.T., di Tomaso, E., Duda, D.G., Munn, L.L., et al. (2009). Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. J. Clin. Oncol. 27, 2542-2552.
    • (2009) J. Clin. Oncol. , vol.27 , pp. 2542-2552
    • Kamoun, W.S.1    Ley, C.D.2    Farrar, C.T.3    Duyverman, A.M.4    Lahdenranta, J.5    Lacorre, D.A.6    Batchelor, T.T.7    Di Tomaso, E.8    Duda, D.G.9    Munn, L.L.10
  • 47
    • 0028025011 scopus 로고
    • Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows
    • Yuan, F., Salehi, H.A., Boucher, Y., Vasthare, U.S., Tuma, R.F., and Jain, R.K. (1994). Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 54, 4564-4568.
    • (1994) Cancer Res. , vol.54 , pp. 4564-4568
    • Yuan, F.1    Salehi, H.A.2    Boucher, Y.3    Vasthare, U.S.4    Tuma, R.F.5    Jain, R.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.